Abstract:
The invention provides conjugates comprising a short isolated peptide coupled to a sphingolipid, the peptide comprising a sequence derived from the HIV-1 gp41. The sphingolipid-peptide conjugates are suitable for treatment of infections caused by human and non-human retroviruses, especially HIV.
Abstract:
Fusion proteins including a type-II cohesin module that are capable of integrating into native and designer cellulosomes. β-glucosidases modified to include a type-II cohesin module and polynucleotides encoding same. Multi-enzyme complexes including the fusion proteins, and methods for biomass degradation utilizing same.
Abstract:
A method of treating cancer is disclosed. The method comprises administering to the subject a therapeutically effective amount of a pharmaceutical composition comprising an agent which induces a dissociation of the 26S proteasomal complex into a 20S component and a 19S component to thereby inhibit 26S proteasomal activity, wherein the pharmaceutical agent is devoid of a chemotherapeutic agent.
Abstract:
Transgenic plants resistant to bio-herbicides, particularly to phytotoxic non-protein amino acids including the meta-tyrosine (m-tyrosine) amino acid analog and salts thereof, means and methods for producing the transgenic plants.
Abstract:
An odorant mixture is disclosed. The odorant mixture comprises N odorant components wherein N equals at least 20. Each odorant component is characterized by a multidimensional vector of attributes. A z score of an average of characteristic distances between vectors corresponding to odorant components in the mixture and vectors corresponding to odorant components in a group of M odorant components but not in the mixture is less than 2.
Abstract:
Method, system and an article of manufacture for clustering and thereby identifying predefined antigens reactive with undetermined immunoglobulins of sera derived from patient subjects in need of diagnosis of disease or monitoring of treatment.
Abstract:
A method for enabling users to offer educational support in response to a designation of instructor identifier (ID) tags associated with network accessible learning documents. The method comprises selecting by a first user using a first client terminal a network accessible learning document, associating an instructor ID tag indicative of the first user with the network accessible learning document, instructing a presentation of the instructor ID tag in association with the presentation of the network accessible learning document to a second user accessing the network accessible learning document via a second client terminal, identifying a user selection designating the instructor ID tag and made by the second user, and establishing a tutorial session which is based on an interactive communication connection between the first user and the second user.
Abstract:
An isolated polypeptide is disclosed comprising an amino acid sequence selected from the group consisting of SEQ ID NOs: 2773-5544 and 11089-11094, wherein the polypeptide has antimicrobial activity. Uses thereof for treating microbial infections are also disclosed.
Abstract translation:公开了分离的多肽,其包含选自SEQ ID NO:2773-5544和11089-11094的氨基酸序列,其中所述多肽具有抗微生物活性。 还公开了其用于治疗微生物感染的用途。
Abstract:
This invention relates to a hybrid component comprising at least one nanoparticle of inorganic layered compound (in the form of fullerene-like structure or nanotube), and at least one metal nanoparticle, uses thereof as a catalyst, (e.g. photocatalysis) and processes for its preparation.